Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

Ratios

vs
industry
vs
history
PE Ratio 28.34
IHE's PE Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 28.34 )
Ranked among companies with meaningful PE Ratio only.
IHE' s PE Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 28.34
PE Ratio without NRI 28.34
IHE's PE Ratio without NRI is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 28.34 )
Ranked among companies with meaningful PE Ratio without NRI only.
IHE' s PE Ratio without NRI Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 28.34
PB Ratio 2.86
IHE's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 2.86 )
Ranked among companies with meaningful PB Ratio only.
IHE' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 2.86

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.90
IHE's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 0.90 )
Ranked among companies with meaningful Dividend Yield % only.
IHE' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 0.9

More Statistics

Short Percentage of Float0.00%
52-Week Range $129.41 - 156.52
Shares Outstanding (Mil)4,650,000.00
» More Articles for IHE

Headlines

Articles On GuruFocus.com
AT&T Invests Nearly $30 Million Over 3-Year Period to Enhance Local Networks in Flint May 27 2017 
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against KBR, Inc May 26 2017 
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against T May 26 2017 
EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Vince Holding Co May 26 2017 
Barrick Gold SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds May 26 2017 
PCM SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS May 26 2017 
CONN'S INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investi May 26 2017 
Weekly Top Insider Buys Highlight for the Week of May 26 May 27 2017 
U-Haul Offers 30 Days of Free U-Box Storage to Storm Victims in Sealy and Wallis May 26 2017 
PBF Energy Announces Expiration and Results of Cash Tender Offer by PBF Holding for Any and All of i May 26 2017 

More From Other Websites
Inside Bristol-Myers Squibb’s Valuation after the 1Q17 Earnings May 18 2017
The Latest Market Trends Every Biopharma Investor Needs to Know May 17 2017
Pfizer’s Corporate and Pipeline Developments in 1Q17 May 09 2017
Pfizer: Why Revenues Fell in 1Q17 for Some Products May 08 2017
Analyzing Pfizer’s 1Q17 Earnings May 05 2017
Analysts’ Ratings and Recommendations for Bristol-Myers Squibb Apr 27 2017
Why medical device stocks may rise if Obamacare is repealed Apr 24 2017
Why some investors aren't thrilled about Becton Dickinson buying C.R. Bard Apr 24 2017
Stocks soar after French elections ahead of busiest earnings week in 10 years Apr 24 2017
How Will Eli Lilly’s Alimta and Other Oncology Products Perform? Apr 21 2017
Johnson & Johnson’s Pharmaceuticals Segment’s 1Q17 Earnings Apr 21 2017
Lackluster J&J Q1 Pushes Healthcare ETFs Down Apr 19 2017
The Larger Aims of Obamacare: An Overview Apr 11 2017
The Hybrid US Healthcare System: An Overview Apr 11 2017
There Is Value To Be Had With The Right Healthcare ETFs Apr 05 2017
There's Value in Healthcare ETFs Apr 04 2017
What’s Pfizer’s Financial Guidance for 2017? Apr 04 2017
What Wall Street Analysts Recommend for Merck Mar 29 2017
Billionaire Investor, Millionaire Mistakes Mar 20 2017
Should You Buy Pharma ETFs Now? Mar 15 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK